Absci
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to create the next generation of protein-based drugs, including Bionic Proteins™ containing nonstandard amino acids, and other novel drug designs that may be impossible to make with other technologies. Our goal is to enable the development of better medicines by Translating Ideas into Drugs™. For more information visit www.absci.com.
Domain
absci.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
101-250
Last Funding
$50.0M
Founded
2010
Tech Stack (32 technologies)
Frequently Asked Questions
What technologies does Absci use?+
Absci uses 32 technologies including Bootstrap, Google Analytics, Google Call Conversion Tracking.
What industry is Absci in?+
Absci operates in the Artificial Intelligence (AI) industry.
Where is Absci based?+
Absci is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026